Immunization, Hib3 in Cyprus
Cyprus: Immunization, Hib3 was 94.0% in 2024. ▲ Rising
Immunization, Hib3 in Cyprus, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Cyprus stood at 94.0%.
Compared with earlier readings it is down 1.1% on the previous year and down 2.1% over ten years.
Over the whole period, immunization, hib3 in Cyprus peaked at 97.0% in 2015 and was at its lowest, 32.0%, in 2000.
Cyprus ranks 64th of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, Hib3 in Cyprus, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2000 | 32.0% | — |
| 2001 | 32.0% | +0.0% |
| 2002 | 32.0% | +0.0% |
| 2003 | 58.0% | +81.2% |
| 2004 | 58.0% | +0.0% |
| 2005 | 58.0% | +0.0% |
| 2006 | 90.0% | +55.2% |
| 2007 | 90.0% | +0.0% |
| 2008 | 90.0% | +0.0% |
| 2009 | 96.0% | +6.7% |
| 2010 | 96.0% | +0.0% |
| 2011 | 96.0% | +0.0% |
| 2012 | 96.0% | +0.0% |
| 2013 | 96.0% | +0.0% |
| 2014 | 96.0% | +0.0% |
| 2015 | 97.0% | +1.0% |
| 2016 | 96.0% | -1.0% |
| 2017 | 96.0% | +0.0% |
| 2018 | 97.0% | +1.0% |
| 2019 | 92.0% | -5.2% |
| 2020 | 92.0% | +0.0% |
| 2021 | 92.0% | +0.0% |
| 2022 | 94.0% | +2.2% |
| 2023 | 95.0% | +1.1% |
| 2024 | 94.0% | -1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.6% | 32.0% | 96.0% | 10 |
| 2010s | 95.8% | 92.0% | 97.0% | 10 |
| 2020s | 93.4% | 92.0% | 95.0% | 5 |
Countries ranked near Cyprus
- 64 Armenia 94.0% compare
- 64 Barbados 94.0% compare
- 64 Botswana 94.0% compare
- 64 Bulgaria 94.0% compare
- 64 Fiji 94.0% compare
- 64 Iceland 94.0% compare
- 64 India 94.0% compare
- 64 Kiribati 94.0% compare
- 64 Poland 94.0% compare
- 64 Seychelles 94.0% compare
- 64 Spain 94.0% compare
- 64 Tuvalu 94.0% compare
- 64 Uruguay 94.0% compare
More health data for Cyprus
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.51 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,325 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0264 units per person (2025)
- Population ages 05-09, male, annual growth rate 1.33 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.028 units per person (2025)
- Population ages 10-14, female, annual growth rate 1.64 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Cyprus?
- Immunization, hib3 in Cyprus was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Cyprus?
- The highest recorded value was 97.0% in 2015.
- What is the lowest immunization, hib3 recorded in Cyprus?
- The lowest recorded value was 32.0% in 2000.
- How does Cyprus rank for immunization, hib3?
- Cyprus ranks 64th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Cyprus?
- Over the last ten years it is down 2.1%. The long-run trend across the full record is rising.
- Where does this Cyprus data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.